Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
EJNMMI Radiopharmacy and Chemistry|February 26, 2024
Preclinical comparison of [<sup>177</sup>Lu]Lu-rhPSMA-10.1 and [<sup>177</sup>Lu]Lu-rhPSMA-10.2 for endoradiotherapy of prostate cancer: biodistribution and dosimetry studiesAlexander Wurzer, Francesco De Rose, Sebastian Fischer, et al.EJNMMI Research|December 7, 2020
Preclinical comparison of four [<sup>18</sup>F, <sup>nat</sup>Ga]rhPSMA-7 isomers: influence of the stereoconfiguration on pharmacokineticsAlexander Wurzer, Mara Parzinger, Matthias Konrad, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 28, 2022
Synthesis and Preclinical Evaluation of <sup>177</sup>Lu-Labeled Radiohybrid PSMA Ligands for Endoradiotherapy of Prostate CancerAlexander Wurzer, Jan-Philip Kunert, Sebastian Fischer, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 8, 2022
Validation of <sup>18</sup>F-rhPSMA-7 and <sup>18</sup>F-rhPSMA-7.3 PET Imaging Results with Histopathology from Salvage Surgery in Patients with Biochemical Recurrence of Prostate CancerMarkus Kroenke, Lilit Schweiger, Thomas Horn, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 13, 2021
The Influence of Specific Activity on the Biodistribution of <sup>18</sup>F-rhPSMA-7.3: A Retrospective Analysis of Clinical PET DataThomas Langbein, Alexander Wurzer, Andrei Gafita, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 5, 2020
Matched-Pair Comparison of <sup>68</sup>Ga-PSMA-11 and <sup>18</sup>F-rhPSMA-7 PET/CT in Patients with Primary and Biochemical Recurrence of Prostate Cancer: Frequency of Non-Tumor-Related Uptake and Tumor PositivityMarkus Kroenke, Lilit Mirzoyan, Thomas Horn, et al.Cancers|December 30, 2025
Digital Twins for Radiopharmaceutical Dosimetry: PBPK Modelling of [<sup>177</sup>Lu]Lu-rhPSMA-10.1 in a Preclinical mCRPC ModelGustavo Costa, Elham Yousefzadeh-Nowshahr, Valentina Vasic, et al.EJNMMI Research|February 4, 2022
Preclinical biodistribution and dosimetry and human biodistribution comparing <sup>18</sup>F-rhPSMA-7 and single isomer <sup>18</sup>F-rhPSMA-7.3Karina Knorr, So Won Oh, Markus Krönke, et al.EJNMMI Radiopharmacy and Chemistry|January 23, 2021
Automated synthesis of [<sup>18</sup>F]Ga-rhPSMA-7/ -7.3: results, quality control and experience from more than 200 routine productionsAlexander Wurzer, Daniel Di Carlo, Michael Herz, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 7, 2022
Utility of <sup>18</sup>F-rhPSMA-7.3 PET for Imaging of Primary Prostate Cancer and Preoperative Efficacy in N-Staging of Unfavorable Intermediate- to Very High-Risk Patients Validated by HistopathologyThomas Langbein, Hui Wang, Isabel Rauscher, et al.Pageof 3